Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
NephroSant, Inc. logo — Kidney Health Redefined

NephroSant, Inc.

Kidney Health Redefined

Founded 2017 United States San Mateo, United States 3 employees Series A Total: $16.00M Biotechnology, Health Care

General Information

Company Name NephroSant, Inc.
Founded Year 2017
Location United States San Mateo, United States
Founders / Decision Makers
Team member
Employees 3
Industries Biotechnology, Health Care
Funding Stage Series A
Business Model B2B, B2B2C
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with NephroSant, Inc.. To contact NephroSant, Inc., visit nephrosant.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NephroSant, Inc. compare?

A PDF of NephroSant, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NephroSant, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NephroSant, Inc.

NephroSant, Inc., founded in 2017, is carving a niche in the Biotechnology and Health Care sectors with their pioneering approach in kidney health. Operating out of the United States, the company is redefining how kidney injuries are detected with their slogan, "Kidney Health Redefined."

The challenge in kidney transplantation lies in the early detection of immune injury, which severely limits the life of a transplant. Addressing this critical need, NephroSant has developed a groundbreaking, cost-effective, and noninvasive assay designed to reliably monitor kidney injury, potentially changing the landscape of kidney transplant care.

The company's potential has been recognized with a $16.00M Series A investment on 16 March 2021 from notable investors including DaVita Venture Group and DigitalDx Ventures. As NephroSant continues to innovate, it represents an appealing opportunity for investors eager to support advances in healthcare technology.

Business keywords: Kidney Health, Kidney Transplantation, Chronic Kidney Disease, Diagnostics, Kidney Injury, Medical Technology, Clinical Research, Physicians, Medical Innovation

Services & Products

The content provided suggests that the domain nephrosant.com is parked and not actively used for business purposes. Therefore
it is not possible to ascertain any core services related to the company.

Target Customers

Due to the lack of specific information in the provided content no target customers or users can be identified.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $16.00M 2
DaVita Venture Group DigitalDx Ventures
DaVita Venture Group, DigitalDx Ventures
01 Mar 2021
Spinout Undisclosed 1
University of California, San Francisco
01 Jan 2017

NephroSant, Inc. Alternatives & Competitors

View All Alternatives
NephroSant, Inc. vs
Santa Barbara Nutrients
Santa Barbara Nutrients United States

We are a team of dedicated researchers and patients bringing to market safe, science-backed products...

19 employees
Biotechnology, Health Care
NephroSant, Inc. vs
Africa Healthcare Network
Africa Healthcare Network Tanzania

Africa Healthcare Network (“AHN”) aims to establish the first dialysis chain across Sub-Saharan Afri...

Venture round
218 employees
Biotechnology, Health Care
NephroSant, Inc. vs
Eliaz Therapeutics Inc
Eliaz Therapeutics Inc United States

A Therapeutic Intervention For Life-Threatening Diseases With No Effective Current Treatments

Grant
7 employees
Biotechnology, Health Care
View all alternatives

FAQ About NephroSant, Inc.

Kidney Health Redefined
NephroSant, Inc. was founded in 2017.
NephroSant, Inc. is headquartered in San Mateo, United States.
NephroSant, Inc. operates in Biotechnology and Health Care. Its work centres on Kidney Health, Kidney Transplantation, Chronic Kidney Disease and Diagnostics. Its customers include Due to the lack of specific information in the provided content and no target customers or users can be identified..
NephroSant, Inc. has a B2B and B2B2C business model. Its revenue comes from Product Sales, Service Fee and Licensing.
NephroSant, Inc. has approximately 3 employees.
NephroSant, Inc. has completed 2 funding rounds, raising a total of $16.00M. The latest funding stage is Series A.
NephroSant, Inc. offers: The content provided suggests that the domain nephrosant.com is parked and not actively used for business purposes. Therefore, it is not possible to ascertain any core services related to the company..
Top alternatives and competitors to NephroSant, Inc. include Santa Barbara Nutrients, Africa Healthcare Network, Eliaz Therapeutics Inc, THRASOS LIMITED, National Kidney Foundation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NephroSant, Inc. and Santa Barbara Nutrients are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NephroSant, Inc., https://bouncewatch.com/company/nephrosant-inc, updated 18 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout